Anti-arthritic effects of the novel dipeptidyl peptidase IV inhibitors TMC-2A and TSL-225. (Q50110219)

25 February 2018

title

Anti-arthritic effects of the novel dipeptidyl peptidase IV inhibitors TMC-2A and TSL-225. (English)

1 reference

25 February 2018

author name string

Tanaka S

1

1 reference

25 February 2018

Murakami T

2

1 reference

25 February 2018

Nonaka N

3

1 reference

25 February 2018

Ohnuki T

4

1 reference

25 February 2018

Yamada M

5

1 reference

25 February 2018

Sugita T

6

1 reference

25 February 2018

publication date

1 July 1998

1 reference

25 February 2018

published in

Immunopharmacology

1 reference

25 February 2018

volume

40

1 reference

25 February 2018

issue

1

1 reference

25 February 2018

page(s)

21-26

1 reference

25 February 2018

Functional role of CD26 on human B lymphocytes

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2898%2900014-9

7 January 2021

Human CD4 helper T cell activation: functional involvement of two distinct collagen receptors, 1F7 and VLA integrin family

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2898%2900014-9

7 January 2021

A new dipeptide naphthylamidase hydrolyzing glycyl-prolyl-beta-naphthylamide

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2898%2900014-9

7 January 2021

Expression and functional role of 1F7 (CD26) antigen on peripheral blood and synovial fluid T cells in rheumatoid arthritis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2898%2900014-9

7 January 2021

TMC-2A, -2B and -2C, Novel Dipeptidyl Peptidase IV Inhibitors Produced by Aspergillus oryzae A374. I.Taxonomy of Producing Strains, Fermentation, and Biochemical Properties.

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2898%2900014-9

7 January 2021

Regulation of the receptor specificity and function of the chemokine RANTES (regulated on activation, normal T cell expressed and secreted) by dipeptidyl peptidase IV (CD26)-mediated cleavage

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2898%2900014-9

7 January 2021

Inhibitors of dipeptidyl peptidase IV (DP IV, CD26) specifically suppress proliferation and modulate cytokine production of strongly CD26 expressing U937 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2898%2900014-9

7 January 2021

Dipeptidyl Peptidase IV in the Immune System. Effects of Specific Enzyme Inhibitors on Activity of Dipeptidyl Peptidase IV and Proliferation of Human Lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2898%2900014-9

7 January 2021

Suppression of arthritis by the inhibitors of dipeptidyl peptidase IV

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2898%2900014-9

7 January 2021

CD26 antigen is a surface dipeptidyl peptidase IV (DPPIV) as characterized by monoclonal antibodies clone TII-19-4-7 and 4EL1C7.

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2898%2900014-9

7 January 2021

Adjuvant polyarthritis. IV. Induction by a synthetic adjuvant: immunologic, histopathologic, and other studies

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2898%2900014-9

7 January 2021

10.1016/S0162-3109(98)00014-9

Identifiers

DOI

1 reference

25 February 2018

1 reference

25 February 2018